Norfloxacin-poly (L-lysine citramide imide) conjugates and structure-dependence of the drug release

Journal of Drug Targeting

Volumn 12, Issue 5, 2004, Pages 297-307

  Gac Breton, Stéphanie ^a   Coudane, Jean ^a   Boustta, Mahfoud ^a   Vert, Michel ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Antibiotic; Drug delivery systems; Macromolecular prodrug; Norfloxacin; Poly(lysine citramide); Spacer

Indexed keywords

ANTIBIOTIC AGENT; CARBAMIC ACID; CARBON 13; CITRIC ACID; DRUG CARRIER; NORFLOXACIN; POLYLYSINE; PRODRUG; PROTON; URETHAN;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG RELEASE; DRUG STRUCTURE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; NORFLOXACIN; NYLONS; SOLUBILITY;

EID: 4644289601     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860410001724477     Document Type: Article

References (17)

1. Abdellaoui, K., Boustta, M., Vert, M., Morjani, H. and Manfait, M. (1998) "Metabolite-derived artificial polymers designed for drug targeting, cell penetration and bioresorption", Eur. J. Pharm. Sci. 6, 61-73.
2. Balazuc, A.-M., Lagranderie, M., Marchal, G., Coessens, V., Rosseeuw, E., Schacht, E. and Domurado, D. (1997) "Efficacité in vivo de la norfloxacine vectorisée vis-à-vis de mycobactéries", XIIth Scientific Meeting of Groupe Thé matique de Recherche sur les Vecteurs, Bruxelles.
3. Boustta, M., Huguet, J. and Vert, M. (1991) "New functional polyamides derived from citric acid and L-lysine: synthesis and characterisation", Makromol. Chem., Macromol. Symp. 47, 345-355.
4. Brion, J.D., Loppinet, V. and Plat, M. (1992) "Quinolones", In: Traité de chimie thérapeutique, eds, Médicaments Antibiotiques (Medicales internationales, Association Française de Chimie Thérapeutique).
5. Coessens, V., Schacht, E. and Domurado, D. (1997) "Synthesis and in vitro stability of macromolecular prodrugs of norfloxacin", J. Control Rel. 47, 283-291.
6. Crémieux, A.-C. (1989) "Pénétration intracellulaire des antibiotiques", La Lettre de l'Infectiologue (Edimark Médica-Press 4, CDTM Editions DaTeBe), pp 787-795.
7. Duncan, R. and Spreafico, F. (1994) "Polymer conjugates. Pharmacokinetics considerations for design and development", Clin. Pharmacokinet. 27, 290-306.
8. Duncan, R., Dimitrijevic, S. and Evagorou, E.G. (1996) "The role of polymer conjugates in the diagnosis and treatment of cancer" , STP Pharma. Sci. 6, 237-263.
9. Gac, S., Coudane, J., Boustta, M., Domurado, D. and Vert, M. (2000) "Synthesis, characterisation and in vivo behaviour of a Norfloxacin-poly(L-lysine citramide imide) conjugate bearing mannosyl residues", J. Drug Target. 7, 393-406.
10. Gautier, S., Boustta, M. and Vert, M. (1997) "Poly(L-lysine citramide) a water-soluble bioresorbable carrier for drug delivery: aqueous solution properties of hydrophobized derivatives", J. Bioact. Compat. Polym. 12, 77-98.
11. Kopecek, J., Cifkova, I., Rejmanova, R, Strohalm, J., Obereigner, B. and Ulbrich, K. (1981) "Polymers containing enzymatically degradable bonds, 4a) Preliminary experiments in vivo" , Makromol. Chem. 182, 2941-2949.
12. Sedlak, M., Buchta, V., Kubicova, L., Simunek, P., Holcapek, M. and Kasparova, P. (2001) "Synthesis and characterisation of a new amphotericin B: methoxypoly(ethylene glycol) conjugate", Bioorg. Med. Chem. Lett. 11(21), 2833-2835.
13. Soyez, H., Schacht, E. and Vanderkerken, S. (1996) "The crucial role of spacer groups in macromolecular prodrugs design", Adv. Drug Delivery Rev. 21, 81-106.
14. Suzawa, T., Nagamura, S., Saito, H., Ohta, S., Hanai, N., Kanazawa, J., Okabe, M. and Yamasaki, M. (2002) "Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker", J. Control. Release 79(1-3), 229-242.
15. Tansey, W., Ke, S., Cao, X.-Y., Pasuelo Marites, J., Wallace, S. and Chun, L. (2004) "Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier", J. Control. Release 94(1), 39-51.
16. Vert, M. (1986) "Polyvalent polymeric drug carriers", CRC Crit. Rev. Ther. Drug Carrier Syst. 2, 291-327.
17. Wolfson, J.S. and Hooper, D.C. (1988) "Norfloxacin: a new targeted fluoroquinolone antimicrobial agent", Ann. Intern. Med. 108, 238-251.